2016 Annual Meeting

November 8 - 13, 2015

Successful translation of nucleic acid therapies into the clinic hinges on efficient delivery into the desired sub-cellular compartment. Achieving this goal of intracellular delivery requires understanding and overcoming a multitude of biological barriers. As such, this session seeks to explore topics associated with (but not limited to) fundamental studies on key extracellular/intracellular pathways, trafficking of delivery vehicles, and design and development of novel carriers, in order to overcome biological barriers resulting in high efficacies of nucleic acid treatments in vitro and in vivo.